clinical trial · NCT05268107
Ethnic Differences in Mechanisms of Action of Dupilumab
University of Michigan·phase4·recruiting·n = 30
Atopic DermatitisDupilumab
brief summary
Previous research has shown that Asian and African Americans are more likely to develop atopic dermatitis (AD) than their Caucasian counterparts. However, limited information is known about AD in Asian and African American populations because most molecular studies have focused on Caucasians with AD. This trial will determine differences in inflammatory responses to dupilumab between Caucasian, Asian, and African American patients with AD. The central hypothesis of this study is that ethnic differences in both immune and stromal cells contribute to variability in AD presentation and response to anti-interleukin-4 receptor (IL-4R) inhibition with dupilumab.
started
Jan 25, 2023
primary completion
Jul 1, 2027
completion
Jan 1, 2028
last updated
Nov 16, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol